04/08/20
The US Food and Drug Administration has given the green light for the country’s first clinical trial of a Japanese flu drug that could be used to treat the coronavirus, according to a report.
The drug favipiravir (pictured here), will be given to some patients in Massachusetts.AFP via Getty Images
Three Massachusetts hospitals were granted approval Tuesday to launch small trials of the antiviral drug favipiravir, a doctor involved in the efforts told the Boston Globe.
The drug, also known by the brand name Avigan, was hailed by Chinese health officials as “clearly effective” when used on 340 patients in trials there that showed reduced recovery time and improved lung function.
The patients given the drug in the Chinese city of Shenzhen tested negative for the virus with a median of four days after becoming positive — much lower than the average of 11 days for those who were not given the medicine, according to the Guardian.
SEE ALSO
These are the drugs being tested in fight against coronavirus
The US trials — which will take place at Massachusetts General Hospital, Brigham and Women’s Hospital, and UMass Memorial Health Care in Worcester — would involve around 50 or 60 patients with COVID-19, the Globe reported.
Continue reading:
https://nypost.com/2020/04/07/fda-ap...r-coronavirus/